Table 3.
Haematological findings in male Swiss Albino mice treated with ruthenium biochanin-A complex for 28 days repeated-dose oral sub-acute toxicity study
| Parameters | Control | ruthenium biochanin-A (50 mg/kg) | Ruthenium biochanin-A (100 mg/kg) | Ruthenium biochanin-A (200 mg/kg) | Ruthenium biochanin-A (400 mg/kg) |
|---|---|---|---|---|---|
| Haemoglobin (Gm%) | 12.4 ± 0.008 | 12.40 ± 0.008 | 12.38 ± 0.009 | 12.36 ± 0.005*# | 12.41 ± 0.006α |
| Total RBC count (×106/µL) | 4.31 ± 0.001 | 4.31 ± 0.001 | 4.32 ± 0.002 | 4.31 ± 0.003 | 4.30 ± 0.001 |
| WBC count (×103/µL) | 5.43 ± 0.001 | 5.49 ± 0.004* | 5.52 ± 0.002* | 5.76 ± 0.003*#$ | 15.12 ± 0.001*#$α |
| Platelet count (×105/µL) | 6.92 ± 0.005 | 6.91 ± 0.002 | 7.07 ± 0.003*# | 7.11 ± 0.002*#$ | 6.87 ± 0.003*$α |
| MCV (fL) | 90.86 ± 0.004 | 88.92 ± 0.008*# | 91.88 ± 0.005*# | 90.88 ± 0.006#$ | 90.95 ± 0.009*#$α |
| MCH (pg) | 28.87 ± 0.003 | 28.75 ± 0.005*# | 27.85 ± 0.005* | 28.77 ± 0.006*$ | 28.88 ± 0.004#$α |
| MCHC (%) | 2.13 ± 0.004 | 31.12 ± 0.005* | 32.13 ± 0.006*# | 32.13 ± 0.006*# | 33.14 ± 0.004*#$α |
| Neutrophil (%) | 55.03 ± 0.006 | 45.34 ± 0.006* | 46.73 ± 0.006*# | 55.07 ± 0.008*#$ | 48.14 ± 0.007*#$α |
| Eosinophil (%) | 2.45 ± 0.01 | 2.55 ± 0.005* | 3.02 ± 0.005*# | 3.46 ± 0.006*#$ | 2.58 ± 0.006*#$α |
| Basophil (%) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Lymphocyte (%) | 45.05 ± 0.12 | 37.05 ± 0.01* | 20.64 ± 0.07*# | 40.17 ± 0.007*#$ | 42.76 ± 0.009*#$α |
| Monocyte (%) | 3.18 ± 0.003 | 3.18 ± 0.005 | 4.03 ± 0.013*# | 3.88 ± 0.006*#$ | 3.56 ± 0.006*#$α |
The values were depicted as mean ± SEM (n = 6). The values were analyzed through one-way ANOVA associated with Tukey’s multiple comparison test
MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, RBC red blood cell, WBC white blood cell
*Significant difference as compared to the control group (p < 0.05)
#Significant difference as compared to the 50 mg/kg complex treated group (p < 0.05)
$Significant difference as compared to the 100 mg/kg complex treated group (p < 0.05)
αSignificant difference as compared to the 200 mg/kg complex treated group (p < 0.05)